Two Sigma Securities’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Two Sigma Securities's VRTX Position: Q3 2026 in Review
Two Sigma Securities sold out of Vertex Pharmaceuticals (VRTX) in Q3 2026, closing a stake of 923 shares — an estimated $458K sold.
Two Sigma Securities first reported a position in VRTX in Q1 2016 and held it in 28 quarters. The position peaked at $14.6M in Q4 2023. 1,793 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Two Sigma Securities reported no remaining Vertex Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Two Sigma Securities sold 923 Vertex Pharmaceuticals shares in Q3 2026, an estimated $458K.
- Two Sigma Securities first reported a position in Vertex Pharmaceuticals in Q1 2016 and held it in 28 quarters.
- Two Sigma Securities's Vertex Pharmaceuticals position peaked at $14.6M in Q4 2023.
- 1,793 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.